• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未经任何干预的肝细胞癌的发生-消退-复发:一例报告

Occurrence-regression-recurrence of hepatocellular carcinoma without any intervention: A case report.

作者信息

Li Weinan, Xiong Yongfu, Shu Xia, Li Jingdong

机构信息

Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.

Department of Gastroenterology, First People's Hospital of Longquanyi District, Chengdu, China.

出版信息

Front Surg. 2022 Sep 12;9:972446. doi: 10.3389/fsurg.2022.972446. eCollection 2022.

DOI:10.3389/fsurg.2022.972446
PMID:36338628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9632955/
Abstract

BACKGROUND

Spontaneous regression of primary liver cancer is a rare event, and currently the exact pathogenesis of spontaneous tumor regression remains unclear.

CASE DESCRIPTION

Clinical information was collected from a patient with spontaneous regression of liver cancer at our center. The patient was a 41-year-old male. He was admitted to the hospital on 3 May 2019, due to aversion to fatty or greasy food, anorexia, loss of appetite, and abdominal distension. Laboratory examination results included hepatitis B surface antigen positivity, hepatitis B e antigen positivity, and hepatitis B core antibody positivity and tumor marker levels of alpha-fetoprotein 142,938.20 µg/L, abnormal prothrombin 4,599.91 mAU/ml, and carbohydrate antigen 19-9 82.05 U/ml. Upper abdominal enhanced computed tomography indicated right hepatocellular carcinoma with portal vein tumor thrombus formation. The patient declined any treatment. The tumor in the right lobe of the liver completely regressed after 1 year, and the patient is still undergoing follow-up.

CONCLUSIONS

We encountered a hepatocellular carcinoma patient who underwent spontaneous regression, but the exact pathogenesis remains unknown. Understanding the pathogenesis of spontaneous regression of hepatocellular carcinoma has the potential to contribute to the development of an effective treatment for hepatocellular carcinoma.

摘要

背景

原发性肝癌的自发消退是一种罕见事件,目前肿瘤自发消退的确切发病机制仍不清楚。

病例描述

我们从本中心一名肝癌自发消退患者处收集了临床信息。该患者为41岁男性。他于2019年5月3日因厌油腻食物、厌食、食欲不振和腹胀入院。实验室检查结果包括乙肝表面抗原阳性、乙肝e抗原阳性、乙肝核心抗体阳性,以及肿瘤标志物甲胎蛋白水平为142,938.20 µg/L、异常凝血酶原4,599.91 mAU/ml和糖类抗原19-9 82.05 U/ml。上腹部增强计算机断层扫描显示右肝细胞癌伴门静脉癌栓形成。患者拒绝任何治疗。肝脏右叶肿瘤在1年后完全消退,患者仍在接受随访。

结论

我们遇到了一名肝细胞癌自发消退的患者,但其确切发病机制仍然未知。了解肝细胞癌自发消退的发病机制可能有助于开发有效的肝细胞癌治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257c/9632955/b21f5587e4cb/fsurg-09-972446-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257c/9632955/8478368fd722/fsurg-09-972446-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257c/9632955/63eea4495822/fsurg-09-972446-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257c/9632955/9e925780de30/fsurg-09-972446-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257c/9632955/b21f5587e4cb/fsurg-09-972446-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257c/9632955/8478368fd722/fsurg-09-972446-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257c/9632955/63eea4495822/fsurg-09-972446-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257c/9632955/9e925780de30/fsurg-09-972446-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257c/9632955/b21f5587e4cb/fsurg-09-972446-g004.jpg

相似文献

1
Occurrence-regression-recurrence of hepatocellular carcinoma without any intervention: A case report.未经任何干预的肝细胞癌的发生-消退-复发:一例报告
Front Surg. 2022 Sep 12;9:972446. doi: 10.3389/fsurg.2022.972446. eCollection 2022.
2
Spontaneous complete regression of hepatocellular carcinoma with portal vein tumor thrombus.伴有门静脉癌栓的肝细胞癌自发完全消退
Hepatogastroenterology. 2003 Sep-Oct;50(53):1628-30.
3
Spontaneous regression of hepatocellular carcinoma repeated 3 times with invasion of portal vein and inferior vena cava: report on a rare case.肝细胞癌伴门静脉及下腔静脉侵犯3次自发消退:1例罕见病例报告
Clin J Gastroenterol. 2012 Feb;5(1):35-41. doi: 10.1007/s12328-011-0266-1. Epub 2011 Dec 9.
4
Spontaneous regression of hepatocellular carcinoma--a case report.肝细胞癌的自发消退——一例报告
Hepatogastroenterology. 2001 Nov-Dec;48(42):1740-2.
5
Spontaneous regression of diffuse intrahepatic recurrence with portal vein tumor thrombus after resection of hepatocellular carcinoma.肝细胞癌切除术后伴有门静脉癌栓的弥漫性肝内复发的自发消退
Clin J Gastroenterol. 2011 Feb;4(1):43-8. doi: 10.1007/s12328-010-0195-4. Epub 2010 Dec 14.
6
Spontaneous regression of a large hepatocellular carcinoma with portal vein tumor thrombi: report of a case.巨大肝细胞癌伴门静脉癌栓自发消退1例报告
Surg Today. 2000;30(1):82-5. doi: 10.1007/PL00010054.
7
A case of resected hepatocellular carcinoma with gallbladder metastasis.一例切除的伴有胆囊转移的肝细胞癌病例。
Surg Case Rep. 2021 Jun 17;7(1):145. doi: 10.1186/s40792-021-01222-7.
8
Spontaneous regression of a large hepatocellular carcinoma: case report.巨大肝细胞癌自发消退:病例报告
Ger Med Sci. 2011 Mar 22;9:Doc07. doi: 10.3205/000130.
9
Favorable response to multimodal treatment in hepatocellular carcinoma with inferior vena cava and right atrial tumor thrombus and left adrenal gland metastasis: A case report and literature review.肝细胞癌伴下腔静脉和右心房肿瘤血栓及左肾上腺转移的多模态治疗的良好反应:病例报告及文献复习。
Medicine (Baltimore). 2021 Dec 10;100(49):e27987. doi: 10.1097/MD.0000000000027987.
10
Hepatocellular carcinoma presenting as an incidental isolated malignant portal vein thrombosis.肝细胞癌表现为偶然发现的孤立性恶性门静脉血栓形成。
J Gastrointest Cancer. 2012 Sep;43(3):486-9. doi: 10.1007/s12029-010-9235-z.

本文引用的文献

1
Surgical Treatment of Postoperative Abdominal Metastases of Hepatocellular Carcinoma: 10-Year Experience in a Single Center.肝细胞癌术后腹腔转移的外科治疗:单中心10年经验
Cancer Manag Res. 2021 Nov 20;13:8673-8683. doi: 10.2147/CMAR.S328250. eCollection 2021.
2
Possible spontaneous regression of hepatocellular carcinoma with unique histopathological features confirmed by surgical resection: a case report.经手术切除证实具有独特组织病理学特征的肝细胞癌可能自发消退:一例报告
Surg Case Rep. 2021 Jul 13;7(1):162. doi: 10.1186/s40792-021-01246-z.
3
Sorafenib derivatives-functionalized gold nanoparticles confer protection against tumor angiogenesis and proliferation via suppression of EGFR and VEGFR-2.
索拉非尼衍生物功能化金纳米粒子通过抑制 EGFR 和 VEGFR-2 来保护肿瘤血管生成和增殖。
Exp Cell Res. 2021 Sep 1;406(1):112633. doi: 10.1016/j.yexcr.2021.112633. Epub 2021 Jun 2.
4
Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study.经动脉化疗栓塞术联合索拉非尼加免疫检查点抑制剂治疗中晚期经动脉化疗栓塞术难治性肝细胞癌的疗效与安全性:一项回顾性研究
Front Mol Biosci. 2021 Jan 15;7:609322. doi: 10.3389/fmolb.2020.609322. eCollection 2020.
5
Single-center experience on actual mid-term (≥5 years) and long-term (≥10 years) survival outcome in patients with hepatocellular carcinoma after curative hepatectomy: A bimodal distribution.肝细胞癌患者根治性肝切除术后实际中期(≥5年)和长期(≥10年)生存结果的单中心经验:双峰分布。
Medicine (Baltimore). 2020 Nov 25;99(48):e23358. doi: 10.1097/MD.0000000000023358.
6
2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights.《2019年中国肝细胞癌管理临床指南:更新与见解》
Hepatobiliary Surg Nutr. 2020 Aug;9(4):452-463. doi: 10.21037/hbsn-20-480.
7
NRF2 Dysregulation in Hepatocellular Carcinoma and Ischemia: A Cohort Study and Laboratory Investigation.NRF2 失调在肝细胞癌和缺血中的作用:一项队列研究和实验室研究。
Radiology. 2020 Oct;297(1):225-234. doi: 10.1148/radiol.2020200201. Epub 2020 Aug 11.
8
Spontaneous regression of stage III neuroblastoma: A case report.Ⅲ期神经母细胞瘤的自发消退:一例报告。
World J Clin Cases. 2020 Jan 26;8(2):436-443. doi: 10.12998/wjcc.v8.i2.436.
9
Spontaneous Regression of Hepatocellular Carcinoma and Review of Reports in the Published English Literature.肝细胞癌的自发消退及英文文献报道综述
Case Rep Med. 2019 Mar 31;2019:9756758. doi: 10.1155/2019/9756758. eCollection 2019.
10
The Epidemiology of Hepatocellular Carcinoma in the USA.美国肝细胞癌的流行病学
Curr Gastroenterol Rep. 2019 Apr 11;21(4):17. doi: 10.1007/s11894-019-0681-x.